Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.

Stalenhoef JE, van Nieuwkoop C, Wilson DC, van der Starre WE, van der Reijden TJK, Delfos NM, Leyten EMS, Koster T, Ablij HC, van 't Wout JJW, van Dissel JT.

BMC Infect Dis. 2019 Feb 14;19(1):161. doi: 10.1186/s12879-019-3789-6.

2.

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.

van Nieuwkoop C, van der Starre WE, Stalenhoef JE, van Aartrijk AM, van der Reijden TJ, Vollaard AM, Delfos NM, van 't Wout JW, Blom JW, Spelt IC, Leyten EM, Koster T, Ablij HC, van der Beek MT, Knol MJ, van Dissel JT.

BMC Med. 2017 Apr 3;15(1):70. doi: 10.1186/s12916-017-0835-3.

3.

Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.

De Vos D, Pirnay JP, Bilocq F, Jennes S, Verbeken G, Rose T, Keersebilck E, Bosmans P, Pieters T, Hing M, Heuninckx W, De Pauw F, Soentjens P, Merabishvili M, Deschaght P, Vaneechoutte M, Bogaerts P, Glupczynski Y, Pot B, van der Reijden TJ, Dijkshoorn L.

PLoS One. 2016 May 25;11(5):e0156237. doi: 10.1371/journal.pone.0156237. eCollection 2016.

4.

Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control study.

van der Starre WE, van Nieuwkoop C, Thomson U, Zijderveld-Voshart MS, Koopman JP, van der Reijden TJ, van Dissel JT, van de Vosse E.

PLoS One. 2015 Mar 25;10(3):e0121302. doi: 10.1371/journal.pone.0121302. eCollection 2015.

5.

Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers.

Esteves F, Calé SS, Badura R, de Boer MG, Maltez F, Calderón EJ, van der Reijden TJ, Márquez-Martín E, Antunes F, Matos O.

Clin Microbiol Infect. 2015 Apr;21(4):379.e1-10. doi: 10.1016/j.cmi.2014.11.025. Epub 2014 Dec 4.

6.

Carbapenem resistance in a human clinical isolate identified to be closely related to Acinetobacter indicus.

Bonnin RA, Poirel L, van der Reijden TJ, Dijkshoorn L, Lescat M, Nordmann P.

Int J Antimicrob Agents. 2014 Oct;44(4):345-50. doi: 10.1016/j.ijantimicag.2014.05.022. Epub 2014 Jul 19.

PMID:
25245212
7.

Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore.

Koh TH, Tan TT, Khoo CT, Ng SY, Tan TY, Hsu LY, Ooi EE, Van Der Reijden TJ, Dijkshoorn L.

Epidemiol Infect. 2012 Mar;140(3):535-8. doi: 10.1017/S0950268811001129. Epub 2011 Jun 21.

PMID:
21733253
8.

Widespread carbapenem resistant Acinetobacter baumannii clones in Italian hospitals revealed by a multicenter study.

Carretto E, Barbarini D, Dijkshoorn L, van der Reijden TJ, Brisse S, Passet V, Farina C; APSI Acinetobacter Study Group.

Infect Genet Evol. 2011 Aug;11(6):1319-26. doi: 10.1016/j.meegid.2011.04.024. Epub 2011 Apr 29.

PMID:
21554997
9.

Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU).

Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L.

Res Microbiol. 2011 May;162(4):393-404. doi: 10.1016/j.resmic.2011.02.006. Epub 2011 Feb 12.

PMID:
21320596
10.

Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center.

Petersen K, Cannegieter SC, van der Reijden TJ, van Strijen B, You DM, Babel BS, Philip AI, Dijkshoorn L.

J Clin Microbiol. 2011 Jan;49(1):159-66. doi: 10.1128/JCM.00766-10. Epub 2010 Nov 17.

11.

Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.

van den Broek PJ, van der Reijden TJ, van Strijen E, Helmig-Schurter AV, Bernards AT, Dijkshoorn L.

J Clin Microbiol. 2009 Nov;47(11):3593-9. doi: 10.1128/JCM.00967-09. Epub 2009 Sep 30.

12.

Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively.

Nemec A, Musílek M, Sedo O, De Baere T, Maixnerová M, van der Reijden TJ, Zdráhal Z, Vaneechoutte M, Dijkshoorn L.

Int J Syst Evol Microbiol. 2010 Apr;60(Pt 4):896-903. doi: 10.1099/ijs.0.013656-0. Epub 2009 Aug 6.

PMID:
19661501
13.

Description of Acinetobacter venetianus ex Di Cello et al. 1997 sp. nov.

Vaneechoutte M, Nemec A, Musílek M, van der Reijden TJ, van den Barselaar M, Tjernberg I, Calame W, Fani R, De Baere T, Dijkshoorn L.

Int J Syst Evol Microbiol. 2009 Jun;59(Pt 6):1376-81. doi: 10.1099/ijs.0.003541-0.

PMID:
19502319
14.

Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans.

Nemec A, Musílek M, Maixnerová M, De Baere T, van der Reijden TJ, Vaneechoutte M, Dijkshoorn L.

Int J Syst Evol Microbiol. 2009 Jan;59(Pt 1):118-24. doi: 10.1099/ijs.0.001230-0.

PMID:
19126734
15.

Can Escherichia coli be used as an indicator organism for transmission events in hospitals?

van den Broek PJ, Bernards AT, van der Reijden TJ, van Strijen B, Dijkshoorn L.

Eur J Clin Microbiol Infect Dis. 2009 Feb;28(2):169-73. doi: 10.1007/s10096-008-0597-0. Epub 2008 Aug 6.

PMID:
18682996
16.

Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.

Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L.

J Antimicrob Chemother. 2008 Sep;62(3):484-9. doi: 10.1093/jac/dkn205. Epub 2008 May 13.

PMID:
18477708
17.

Reclassification of Acinetobacter grimontii Carr et al. 2003 as a later synonym of Acinetobacter junii Bouvet and Grimont 1986.

Vaneechoutte M, De Baere T, Nemec A, Musílek M, van der Reijden TJ, Dijkshoorn L.

Int J Syst Evol Microbiol. 2008 Apr;58(Pt 4):937-40. doi: 10.1099/ijs.0.65129-0.

PMID:
18398198
18.

Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains.

Nemec A, Maixnerová M, van der Reijden TJ, van den Broek PJ, Dijkshoorn L.

J Antimicrob Chemother. 2007 Sep;60(3):483-9. Epub 2007 Jun 26.

PMID:
17595288
19.

Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands.

Brimicombe RW, Dijkshoorn L, van der Reijden TJ, Kardoes I, Pitt TL, van den Broek PJ, Heijerman HG.

J Cyst Fibros. 2008 Jan;7(1):30-6. Epub 2007 May 25.

20.

Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001.

van den Broek PJ, Arends J, Bernards AT, De Brauwer E, Mascini EM, van der Reijden TJ, Spanjaard L, Thewessen EA, van der Zee A, van Zeijl JH, Dijkshoorn L.

Clin Microbiol Infect. 2006 Sep;12(9):837-43.

21.

Rapid epidemiological analysis of Acinetobacter strains by Raman spectroscopy.

Maquelin K, Dijkshoorn L, van der Reijden TJ, Puppels GJ.

J Microbiol Methods. 2006 Jan;64(1):126-31. Epub 2005 Jun 1.

PMID:
15935496
22.

Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals.

Dijkshoorn L, van Aken E, Shunburne L, van der Reijden TJ, Bernards AT, Nemec A, Towner KJ.

Clin Microbiol Infect. 2005 Apr;11(4):329-32.

23.

Persistent Acinetobacter baumannii? Look inside your medical equipment.

Bernards AT, Harinck HI, Dijkshoorn L, van der Reijden TJ, van den Broek PJ.

Infect Control Hosp Epidemiol. 2004 Nov;25(11):1002-4.

PMID:
15566039
25.

Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic.

Nemec A, Dijkshoorn L, van der Reijden TJ.

J Med Microbiol. 2004 Feb;53(Pt 2):147-53.

PMID:
14729937
26.

Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens.

Nemec A, Dijkshoorn L, Cleenwerck I, De Baere T, Janssens D, Van Der Reijden TJ, Jezek P, Vaneechoutte M.

Int J Syst Evol Microbiol. 2003 Sep;53(Pt 5):1563-7.

PMID:
13130049
27.

Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.

Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, Dijkshoorn L.

Int J Syst Evol Microbiol. 2001 Sep;51(Pt 5):1891-9.

PMID:
11594623
28.

Adherence to a metal, polymer and composite by Staphylococcus aureus and Staphylococcus epidermidis.

Verheyen CC, Dhert WJ, de Blieck-Hogervorst JM, van der Reijden TJ, Petit PL, de Groot K.

Biomaterials. 1993 Apr;14(5):383-91.

PMID:
8507783
29.

Evaluation of commercial test systems for the identification of nonfermenters.

Lampe AS, van der Reijden TJ.

Eur J Clin Microbiol. 1984 Aug;3(4):301-5.

PMID:
6386458
30.

Activity of cephalosporins against methicillin-resistant coagulase-negative staphylococci.

Mouton RP, Lampe AS, van Maanen DB, van der Reijden TJ.

Eur J Clin Microbiol. 1984 Apr;3(2):144-6.

PMID:
6562960

Supplemental Content

Loading ...
Support Center